{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011384","form_type":"8-K","ticker":"FBIO","cik":"0001429260","company_name":"Fortress Biotech, Inc.","filed_at":"2023-06-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.834498+00:00","generated_at":"2026-06-13T17:52:23.552708+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Fortress Biotech stockholders approve 7M share increase in incentive plan and 1M in ESPP","bullets":["Stockholders re-elected all eight director nominees to hold office until the 2024 annual meeting.","Ratified KPMG as independent auditor for 2023 with over 99.6% of votes in favor.","Approved amendment to 2013 Stock Incentive Plan: shares increased by 7M to 23M total, term extended to Dec 31, 2033.","Approved amendment to 2012 ESPP: shares increased by 1M to 2M total.","Both plan amendments became effective upon stockholder approval on June 21, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011384","json":"https://secwatch.observer/filing/0001558370-23-011384.json","markdown":"https://secwatch.observer/filing/0001558370-23-011384.md","text":"https://secwatch.observer/filing/0001558370-23-011384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/fbio-20230621x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T17:52:23.552708+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0c832ac79ca0278852d89d3466e0208c75a5ba57","claim":"Fortress Biotech, Inc. shareholders approved Amendment to the Incentive Plan to increase the shares of Common Stock available for issuance under the Incentive Plan by 7,000,000 shares from 16,000,000 to 23,000,000 and extend the term of the plan to December 31, 2033 at the 2023-06-21 meeting.","evidence_excerpt":"Proposal 3 The vote with respect to the approval of an amendment to Fortress’s Incentive Plan was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 62,543,510 3,400,208 114,917 34,919,105","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"},{"claim_id":"35b61e87c1167226da0d3861004bbfa9c3df0fa2","claim":"Fortress Biotech, Inc. shareholders approved Election of eight directors to hold office until the 2024 annual meeting of stockholders or until such director resigns or is removed from office at the 2023-06-21 meeting.","evidence_excerpt":"Proposal 1 The votes with respect to the election of eight directors to hold office until the 2024 annual meeting of stockholders were as follows: Director Votes For Votes Withheld Broker Non-Votes Lindsay A. Rosenwald, M.D. ​ 65,231,237 ​ 827,398 ​ 34,919,105 Michael S. Weiss ​ 63,192,696 ​ 2,865,939 ​ 34,919,105 Eric R. Rowinsky, M.D. ​ 59,716,534 ​ 6,342,101 ​ 34,919,105 J. Jay Lobell ​ 63,930,573 ​ 2,128,062 ​ 34,919,105 Jimmie Harvey, Jr., M.D. ​ 65,276,580 ​ 782,055 ​ 34,919,105 Dov Klein, C.P.A. ​ 60,924,252 ​ 5,134,383 ​ 34,919,105 Malcolm Hoenlein ​ 60,908,825 ​ 5,149,810 ​ 34,919,105 Kevin L. Lorenz, J.D. ​ 60,998,382 ​ 5,060,253 ​ 34,919,105 Lucy Lu, M.D. ​ 64,968,753 ​ 1,089,882 ​ 34,919,105","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"},{"claim_id":"a23450001b6fa6317f4caf4c49d3d122882df122","claim":"Fortress Biotech, Inc. shareholders approved Amendment to the ESPP to increase the shares of Common Stock available for issuance under the ESPP by 1,000,000 from 1,000,000 to 2,000,000 at the 2023-06-21 meeting.","evidence_excerpt":"Proposal 4 The vote with respect to the approval of an amendment to Fortress’s ESPP was as follows: Total Votes For Total Votes Against Abstentions Broker Non-Votes 63,118,584 2,791,004 149,047 34,919,105","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"},{"claim_id":"fd845f28573b485d40337dec42175be506ef2d72","claim":"Fortress Biotech, Inc. shareholders approved Ratification of the appointment of KPMG LLP as Fortress's independent registered public accounting firm for the year ending December 31, 2023 at the 2023-06-21 meeting.","evidence_excerpt":"Proposal 2 The vote with respect to the ratification of KPMG LLP as Fortress’s independent registered accounting firm for the year ending December 31, 2023 was as follows: Total Votes For Total Votes Against Abstentions 100,561,358 349,645 66,737","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1429260/000155837023011384/0001558370-23-011384-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-21"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}